A Phase 3 clinical trial has demonstrated that patients with advanced (Stage 3 or 4) classic Hodgkin lymphoma who underwent initial treatment with nivolumab, a PD-1 checkpoint inhibitor, combined with...

City of Hope scientists shared breakthrough research and innovative studies at this year's American Association for Cancer Research (AACR) Annual Meeting, which took place April 14 to 19 in Orlando...

Usually we write about successful trials that introduce new, advanced treatments. This article, though, is about a trial that failed — but a failure that was so significant, it was...

Scientists at City of Hope have developed a novel blood test that may in the future be used to detect early-onset colorectal cancer, which has been on the rise in...

Imagine there’s a “boiling point” for cancer — an exact point at which a normal cell becomes malignant, just as water becomes vapor at 212 degrees Fahrenheit. Once we discovered...

Energy, passion and a unique talent for both surgery and science have launched a notable medical career for Mustafa Raoof, M.D., M.S., a surgical oncologist and researcher specializing in gastrointestinal...

Can a simple genetic test predict how susceptible you are to COVID-19? According to a recent study published in the Journal of Virology, the answer may be yes.  ...

City of Hope surgical researchers are the first in the nation to open a clinical trial that could one day become an effective way to deliver chemotherapy to abdominal cancer...

The Epstein-Barr virus (EBV) is best known for causing mononucleosis, or “mono,” but it is also linked to several types of cancer, including lymphomas and carcinomas. With more than 90%...

City of Hope scientists have combined two potent immunotherapies — an oncolytic virus and chimeric antigen receptor (CAR) T cell therapy — to target and eradicate solid tumors that are...